전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved62 programs
AntibodyCurated CoreFDANovo NordiskApproved

semaglutide (Ozempic / Wegovy, GLP-1, Wegovy, NN9535)

Type 2 diabetes, chronic weight management, CV risk reduction (T2D) · GLP-1 receptor

#GLP-1receptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 410Status Approved
AntibodyCurated CoreFDAEli LillyApproved

tirzepatide (Mounjaro / Zepbound, Mounjaro, Zepbound, LY3298176)

Type 2 diabetes, chronic weight management · GLP-1 / GIP receptor

#GLP-1GIPreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 269Status Approved
AntibodyCurated CoreFDAargenxApproved

efgartigimod (Vyvgart, ARGX-113, Vyvgart Hytrulo, efgartigimod alfa-fcab)

Generalized myasthenia gravis (AChR antibody positive), chronic inflammatory demyelinating polyneuropathy · FcRn (neonatal Fc receptor)

#FcRnneonatalFcreceptor#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 48Status Approved
AntibodyCurated CoreFDAAstraZenecaApproved

tezepelumab (Tezspire, AMG 157, MEDI9929, tezepelumab-ekko)

Severe asthma add-on maintenance, chronic rhinosinusitis with nasal polyps · TSLP (thymic stromal lymphopoietin)

#TSLPthymicstromallymphopoietin#Antibody#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 47Status Approved
AntibodyCurated CorestaleRocheApproved

Tocilizumab (Tocilizumab)

Multiple Myeloma (MM); Multiple Myeloma Refractory · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 161Status Recruiting
AntibodyLimited DatastaleRocheApproved

Omalizumab (Omalizumab)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP); Chronic Rhinosinusitis (CRS) · Persistent Allergic Asthma

#PersistentAllergicAsthma#Antibody#Approved#Popular#monoclonal-antibody+4
Trials 89Status Active
AntibodyCurated CorestaleNovartisPhase 3

Ofatumumab (Ofatumumab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Leukemia

#Leukemia#Antibody#Phase3#BioJungboMoa-pick#Popular+5
Trials 85Status Recruiting
AntibodyCurated CorestaleBelfast Health and Social Care …Approved

Golimumab (Golimumab)

Psoriatic Arthritis; Psoriasis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 80Status Discontinued
CGTLimited DatastaleLion TCR Pte. Ltd.Phase 1

TCR-T (TCR-T)

Chronic Hepatitis B · Chronic Hepatitis B

#ChronicHepatitisB#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 60Status Active
AntibodyLimited DatastaleUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
CGTStandard DatabasestalePfizerPhase 2

Trimethoprim-sulfamethoxazole (Trimethoprim-sulfamethoxazole)

Chronic Myeloproliferative Disorders; Infection · Chronic Myeloproliferative Disorders

#ChronicMyeloproliferativeDisorde#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTLimited DatastaleGilead SciencesPhase 1

Ledipasvir-Sofosbuvir (Ledipasvir-Sofosbuvir)

Chronic Hepatitis C · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Phase1#Popular#cell-gene-therapy+4
Trials 57Status Active
CGTLimited DatastaleBristol-Myers SquibbPhase 1

Daclatasvir-Sofosbuvir (Daclatasvir-Sofosbuvir)

Chronic Hepatitis C · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Phase1#Popular#cell-gene-therapy+3
Trials 56Status Active
CGTStandard DatabasestaleNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Active
AntibodyCurated CorestaleGSKApproved

Mepolizumab (Mepolizumab)

Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic · Asthma

#Asthma#Antibody#Approved#BioJungboMoa-pick#Popular+5
Trials 54Status Active
CGTStandard DatabasestaleGlaxoSmithKlinePhase 2

Eltrombopag (Eltrombopag)

Chronic Granulomatous Disease (CGD) · Chronic Granulomatous Disease (CGD)

#ChronicGranulomatousDiseaseCGD#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 53Status Active
AntibodyLimited DatastaleRochePhase 2

Bendamustine + Rituximab (Bendamustine + Rituximab)

Marginal Zone Lymphoma(MZL) · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 52Status Recruiting
CGTStandard DatabasestaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTStandard DatabasestaleIncyte CorporationPhase 2

pentostatin (pentostatin)

Chronic Myeloproliferative Disorders; Leukemia · Chronic Myeloproliferative Disorders

#ChronicMyeloproliferativeDisorde#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 45Status Discontinued
CGTStandard DatabasestaleJuno Therapeutics, a Subsidiary…Phase 2

lisocabtagene maraleucel (JCAR017, JCAR017 (lisocabtagene maraleucel))

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 34Status Recruiting

1 / 4 pages

← PreviousNext →